gout

Macro texture of green pink and blue gemstones Sparkling luxury crystal pattern

Biotech

Crystalys mines $130M series B to push gout drug through phase 3

The series B comes less than a year after Crystalys emerged from stealth with an impressive $205 million series A round in September 2025.

Marissa Russo Jul 22, 2026 8:00am

FDA stop sign

Fierce Pharma

FDA snubs Sobi’s gout drug over manufacturing issues

Jun 29, 2026 11:04am

Gout foot

Sobi pays $950M upfront to snap up gout specialist Arthrosi

Dec 15, 2025 8:15am

Novo Nordisk

Novo drops oncology ambitions, early-stage MASH prospects

Nov 5, 2025 7:21am

money flying in

Arthrosi raises $153M, fueling dash toward phase 3 gout data

Oct 8, 2025 10:15am

A close-up view of a jigsaw puzzle with a missing piece

Novo Holdings-backed biotech raises $205M to fill gout care gap

Sep 30, 2025 8:00am